Business Context and Reporting Period
This Form 8-K is filed by ChromaDex Corp. (not Niagen Bioscience, Inc.) on June 12, 2012. The report details significant changes in executive leadership and board composition effective June 11, 2012.
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, or debt levels. The only financial data disclosed relates to executive separation agreements:
- Jeffrey Himmel (Former CEO/President): Entitled to a lump sum payment of approximately $285,000.
- Debra Heim (Former COO): Entitled to a lump sum payment of approximately $76,000.
- Stock Transaction: A trust associated with Mr. Himmel agreed to sell 1,333,333 shares of common stock to certain stockholders.
Material Changes
The filing reports the following material changes in corporate governance and management:
- Appointment: Frank Jaksch, previously Chief Scientific Officer, was appointed as Chief Executive Officer and President.
- Resignations: Jeffrey Himmel voluntarily resigned as CEO, President, and member of the Board of Directors. Debra Heim voluntarily resigned as Chief Operating Officer and President of the Consumer Products Division.
- Agreements: Separation and Release Agreements were executed with both Mr. Himmel and Ms. Heim.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, future outlook, or specific risk factors beyond the disclosure of the leadership transition. The company issued a press release (Exhibit 99.1) to publicly announce these changes under Regulation FD.
Investor Verification Checklist
- Verify the terms of the Separation and Release Agreements (Exhibits 10.1 and 10.2) for any additional compensation or restrictions not summarized in the text.
- Confirm the identity of the "certain stockholders" purchasing the 1,333,333 shares from Mr. Himmel's trust.
- Review the full press release (Exhibit 99.1) for any strategic context regarding the leadership change.
- Note that the company name in the metadata request ("Niagen Bioscience") does not match the registrant in the filing ("ChromaDex Corp."); verify if this is a historical name change or a data error.